Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technique finds molecules necessary for cancer metastasis

05.04.2005


Provides unique drug targets to prevent spread

Tufts University researchers have identified several proteins on the surface of cancer cells that contribute to the cells’ ability to metastasize. When the researchers destroyed these particular proteins, the cancerous cells show a significant decrease in their ability to invade healthy cells – a finding that provides a new target for badly needed drugs. Although most cancer deaths occur from metastasis, not from the original cancer itself, no drug treatments are currently available specifically to prevent the spread of the cancer from the original site to other organs. The team also has discovered new roles related to the spread of cancer in two molecules known for other, non-cancer activities.

Dr. Daniel Jay presented the study on Sunday, April 3, at Experimental Biology 2005 in San Diego, as part of the scientific sessions of the American Society for Biochemistry and Molecular Biology.



The findings were made possible, says Dr. Jay, because he and his colleagues have developed a new Fluorform-Assisted Light Inactivation technology (FALI) that is a new generation of the Chromophore-Assisted Laser Inactivation (CALI) technique he created 17 years ago to inactivate specific proteins in living cells at precise times and locations. The researchers are able to destroy a specific protein, sparing all other proteins attached to the cell as well as the cell itself, by targeting the antibody to that specific cell. They tag the antibody with a dye that absorbs a specific wavelength of light. When the light is turned on (earlier technology required lasers; the new FALI technology needs only the light of a slide projector), the light energy absorbed by the dye in the antibody generates free radicals that destroy the specific protein bound by that antibody.

What gives the new FALI approach its power, says Dr. Jay, is its high throughput and its ability to couple with the large antibody libraries now available. Whereas the team used to look at one protein at a time, it now can rapidly scan thousands of the proteins associated with cancer cells, systematically "knocking out" one at a time and looking for those whose absence on the cell causes a significant decrease in invasiveness.

At the Experimental Biology 2005, Dr. Jay also describes two of the molecules identified by the FALI approach to have large implications for metastasis. Both were well known to scientists, but the Jay team is the first to recognize the roles they play in cancer. The first molecule, HSP90A, is a molecular chaperone that facilities the folding and activation of different proteins within the cells. The Jay laboratory was the first to recognize HSP90A also had a role outside the cell; it activates a particular matrix metalloprotease required for restructuring the surrounding matrix as cells move and invade.

The second molecule, the polio virus receptor CD155, has been recognized for decades as the pathway by which the polio virus is able to enter motor neurons in the nervous system. Dr. Jay and his team have found that the receptor also plays a role in how brain tumor cells move in the brain, spreading to healthy cells.

"Our current interest is cell motility related to the spread of cancer," says Dr. Jay, "but the speed and sensitivity of the FALI approach gives it wide applicability as a method to identify functionally important proteins in a variety of disease processes."

Coauthors of the presentation are Brenda Eustace, Takashi Sakurai, and Kevin Sloan. Funding for the study came from the National Cancer Institute and the Goldhirsh Foundation.

Sarah Goodwin | EurekAlert!
Further information:
http://www.faseb.org/

More articles from Life Sciences:

nachricht Enduring cold temperatures alters fat cell epigenetics
19.04.2018 | University of Tokyo

nachricht Full of hot air and proud of it
18.04.2018 | University of Pittsburgh

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>